Episode 499: APCCC 2026 - Radioligands in Prostate Cancer
From The Uromigos · · 37 min
This plays from the publisher's own server. We do not host a copy.
Not rated yet
Description
This session features expert Michael Morris discussing radioligand therapy, adaptive dosing, retreatment strategies, and the latest insights in prostate cancer treatment. Gain a deep understanding of current practices, challenges, and future directions in radiopharmaceuticals.